{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:10:16Z","timestamp":1788973816050,"version":"build-2803163510"},"reference-count":26,"publisher":"Informa UK Limited","issue":"sup6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegener. Dis. Manag."],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.2217\/nmt-2017-0033","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T10:56:56Z","timestamp":1510829816000},"page":"3-6","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Biomarkers in the Evolution of Multiple Sclerosis"],"prefix":"10.1080","volume":"7","author":[{"given":"Thomas","family":"Berger","sequence":"first","affiliation":[{"name":"Clinical Department of Neurology Medical University of Innsbruck\r          Anichstrasse 35\r          Innsbruck\r          6020\r          Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.22102"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70233-3"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000235944"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.8.897"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318259e1b2"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508096878"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-184"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.2956"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.11.013"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308346"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000175"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000280576.73609.c6"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq035"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514561906"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-1195"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003085"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.11.2055"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070941"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044396"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511404271"},{"key":"e_1_3_2_25_1","unstructured":"US Food and Drug Administration . Highlights of prescribing information: ZINBRYTA\u00ae (daclizumab) injection for subcutaneous use . www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761029s000lbl.pdf ."},{"issue":"14","key":"e_1_3_2_26_1","article-title":"Anti-JC virus (JCV) antibody index differentiates risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients with no prior immunosuppressant use: an updated analysis","volume":"84","author":"Kuesters G","year":"2015","unstructured":"Kuesters G , PlavinaT, LeeSet al. Anti-JC virus (JCV) antibody index differentiates risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients with no prior immunosuppressant use: an updated analysis . Neurology84 ( 14 ), Supplement P4.031 ( 2015 ).","journal-title":"Neurology"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174005"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nmt-2017-0033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:47:01Z","timestamp":1716493621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nmt-2017-0033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":26,"journal-issue":{"issue":"sup6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.2217\/nmt-2017-0033"],"URL":"https:\/\/doi.org\/10.2217\/nmt-2017-0033","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}